Claims the Bears are drastically improved personnel-wise as the full team reports to their first camp under Ben Johnson on Tuesday are probably overly optimistic.

Keeping it in the family can hurt the bottom line when it comes to family businesses and their private investment firms, according to consultant Joshua Gentine.

The company plans to expand the BIO*Asterix line with both proprietary and non-proprietary itaconate derivatives, supporting long-term growth in the acrylic acid market. CTO Dr. Yvon Durant noted that ...

Ninety One reported a rise in assets under management over the first quarter of fiscal 2026, driven partly by the transfer of assets from South Africa's Sanlam.